Study S000871

Tapered Versus Abrupt Discontinuation of Semaglutide After Treatment of Recurrent Weight Gain or Suboptimal Response Following Metabolic and Bariatric Surgery: a Randomized, Double-blind Trial

ClinicalTrials.gov record

Registration

Registration: NCT07859176
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: QUADRUPLE
Status: NOT_YET_RECRUITING
Enrollment: 100
Start: 2026-10
Primary completion: 2028-04
Lead sponsor: General Committee of Teaching Hospitals and Institutes, Egypt
Conditions: Morbid Obesity
Interventions: DRUG:Semaglutide weekly injection; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Percentage change in body weight [Baseline till 18 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.